Key Record Dates
ClinicalTrials.gov Identifier: | NCT05982704 |
---|---|
Brief Title: | Study of Tixagevimab/Cilgavimab and Regdanvimab Efficacy for Treatment of COVID-19 |
First Submitted : | August 7, 2023 |
First Submitted that Met QC Criteria : | August 7, 2023 |
First Posted : | August 8, 2023 |
Last Update Submitted that Met QC Criteria : | August 7, 2023 |
Last Update Posted : | August 8, 2023 |